Karuna Sundarapandiyan

642 total citations
18 papers, 506 citations indexed

About

Karuna Sundarapandiyan is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Karuna Sundarapandiyan has authored 18 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Karuna Sundarapandiyan's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Karuna Sundarapandiyan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Karuna Sundarapandiyan collaborates with scholars based in United States, Netherlands and Germany. Karuna Sundarapandiyan's co-authors include Tibor Keler, Yashwant M. Deo, Robert F. Graziano, Paul K. Wallace, Laura Vitale, R F Graziano, Jan G. J. van de Winkel, Henry C. Marsh, Venky Ramakrishna and Max Bylesjö and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Karuna Sundarapandiyan

17 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karuna Sundarapandiyan United States	11	355	279	185	180	27	18	506
Saskia Meyer Netherlands	11	298 0.8×	242 0.9×	169 0.9×	99 0.6×	27 1.0×	16	454
Annie Galinha France	15	435 1.2×	354 1.3×	343 1.9×	187 1.0×	37 1.4×	26	718
Jean Decker United States	6	254 0.7×	94 0.3×	124 0.7×	95 0.5×	27 1.0×	9	389
Jinghua Wu China	12	286 0.8×	89 0.3×	149 0.8×	124 0.7×	24 0.9×	18	448
Antonio Ortiz Buijsse Netherlands	5	205 0.6×	294 1.1×	258 1.4×	194 1.1×	29 1.1×	6	559
Joan L. Klotz United States	12	444 1.3×	282 1.0×	186 1.0×	90 0.5×	20 0.7×	22	647
S. Goldberg United States	11	288 0.8×	63 0.2×	124 0.7×	182 1.0×	23 0.9×	15	439
Akito Natsume Japan	9	294 0.8×	543 1.9×	442 2.4×	142 0.8×	24 0.9×	9	684
Szilvia Mosolits Sweden	12	334 0.9×	93 0.3×	148 0.8×	247 1.4×	24 0.9×	15	478
Ulf Forssmann Germany	11	207 0.6×	104 0.4×	189 1.0×	152 0.8×	13 0.5×	24	409

Countries citing papers authored by Karuna Sundarapandiyan

Since Specialization

Citations

This map shows the geographic impact of Karuna Sundarapandiyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karuna Sundarapandiyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karuna Sundarapandiyan more than expected).

Fields of papers citing papers by Karuna Sundarapandiyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karuna Sundarapandiyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karuna Sundarapandiyan. The network helps show where Karuna Sundarapandiyan may publish in the future.

Co-authorship network of co-authors of Karuna Sundarapandiyan

This figure shows the co-authorship network connecting the top 25 collaborators of Karuna Sundarapandiyan. A scholar is included among the top collaborators of Karuna Sundarapandiyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karuna Sundarapandiyan. Karuna Sundarapandiyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gandhapudi, Siva K., Karuna Sundarapandiyan, Lauren V. Wood, et al.. (2023). Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses. 15(2). 432–432. 8 indexed citations

Gandhapudi, Siva K., Karuna Sundarapandiyan, Afsheen Fatima, et al.. (2022). Abstract B24: Development of targeted T-cell cancer immunotherapies based on a novel enantiomeric cationic lipid that promotes antigen cross-presentation and upregulation of type I interferons. Cancer Immunology Research. 10(12_Supplement). B24–B24. 1 indexed citations

Wood, Lauren V., et al.. (2020). R-DOTAP (Versamune): A novel enantiospecific cationic lipid nanoparticle that induces CD4 and CD8 cellular immune responses to whole protein and tumor-specific peptide antigens.. Journal of Clinical Oncology. 38(15_suppl). e15211–e15211. 5 indexed citations

Vitale, Laura, Lawrence J. Thomas, Li-Zhen He, et al.. (2018). Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy. Cancer Immunology Immunotherapy. 68(2). 233–245. 39 indexed citations

Thomas, Lawrence J., Laura Vitale, Thomas J. O’Neill, et al.. (2016). Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1. Molecular Cancer Therapeutics. 15(12). 2946–2954. 34 indexed citations

Vitale, Laura, Thomas J. O’Neill, Jenifer Widger, et al.. (2016). Abstract 4866: Development and characterization of novel CD40 antibody agonists for cancer immunotherapy. Cancer Research. 76(14_Supplement). 4866–4866. 1 indexed citations

Ramakrishna, Venky, Karuna Sundarapandiyan, Biwei Zhao, et al.. (2015). Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab. Journal for ImmunoTherapy of Cancer. 3(1). 37–37. 51 indexed citations

Sundarapandiyan, Karuna, Laura Vitale, Biwei Zhao, et al.. (2013). Abstract 1239: Characterization of the response of human T cells to an agonist human anti-CD27 mAb.. Cancer Research. 73(8_Supplement). 1239–1239. 1 indexed citations

He, Li-Zhen, Larry L. Thomas, Laura Vitale, et al.. (2011). Development of a Human Anti-CD27 Antibody with Efficacy in Lymphoma and Leukemia Models by Two Distinct Mechanisms. Blood. 118(21). 2861–2861. 5 indexed citations

10.

Sundarapandiyan, Karuna, Tibor Keler, Detlev Behnke, et al.. (2001). Bispecific antibody-mediated destruction of Hodgkin’s lymphoma cells. Journal of Immunological Methods. 248(1-2). 113–123. 27 indexed citations

11.

Keler, Tibor, Paul M. Guyre, Laura Vitale, et al.. (2000). Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice. The Journal of Immunology. 165(12). 6738–6742. 49 indexed citations

12.

Keler, Tibor, Paul K. Wallace, Laura Vitale, et al.. (2000). Differential Effect of Cytokine Treatment on Fcα Receptor I- and Fcγ Receptor I-Mediated Tumor Cytotoxicity by Monocyte-Derived Macrophages. The Journal of Immunology. 164(11). 5746–5752. 36 indexed citations

13.

Stockmeyer, Bernhard, Michael Dechant, Marjolein van Egmond, et al.. (2000). Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy. The Journal of Immunology. 165(10). 5954–5961. 98 indexed citations

14.

Sundarapandiyan, Karuna, et al.. (1999). Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells. Human Antibodies. 9(1). 47–54. 15 indexed citations

15.

Deo, Yashwant M., Karuna Sundarapandiyan, Tibor Keler, Paul K. Wallace, & R F Graziano. (1998). Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.. PubMed. 160(4). 1677–86. 50 indexed citations

16.

Deo, Yashwant M., Karuna Sundarapandiyan, Tibor Keler, Paul K. Wallace, & Robert F. Graziano. (1998). Bispecific Molecules Directed to the Fc Receptor for IgA (FcαRI, CD89) and Tumor Antigens Efficiently Promote Cell-Mediated Cytotoxicity of Tumor Targets in Whole Blood. The Journal of Immunology. 160(4). 1677–1686. 51 indexed citations

17.

Goldstein, Julia, R F Graziano, Karuna Sundarapandiyan, Chandra Somasundaram, & Yashwant M. Deo. (1997). Cytolytic and cytostatic properties of an anti-human Fc γRI (CD64) x epidermal growth factor bispecific fusion protein. The Journal of Immunology. 158(2). 872–879. 29 indexed citations

18.

Graziano, Robert F., et al.. (1997). Targeting tumor cell destruction with CD64-directed bispecific fusion proteins. Cancer Immunology Immunotherapy. 45(3-4). 124–127. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact